Discontinuation report SEBIVO
| Report ID | 89042 |
| Drug Identification Number | 02288389 |
| Brand name | SEBIVO |
| Common or Proper name | SEBIVO 600MG 2 X 14 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TELBIVUDINE |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 2 X 14 |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-11-01 |
| Actual discontinuation date | 2019-11-01 |
| Remaining supply date | 2019-11-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Expiration date of remaining supply: April 30, 2020 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-11-06 | French | Compare |
| v6 | 2019-11-06 | English | Compare |
| v5 | 2019-09-05 | English | Compare |
| v4 | 2019-07-10 | French | Compare |
| v3 | 2019-07-10 | English | Compare |
| v2 | 2019-07-10 | French | Compare |
| v1 | 2019-07-10 | English | Compare |
Showing 1 to 7 of 7